PubRank

Susan E Andrade

Author PubWeight™ 75.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 2004 5.25
2 Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008 2.82
3 ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 2011 2.77
4 Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care 2005 2.33
5 Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 2007 2.09
6 Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 2007 2.03
7 A critical review of methods to evaluate the impact of FDA regulatory actions. Pharmacoepidemiol Drug Saf 2013 2.00
8 A systematic review of validated methods for identifying heart failure using administrative data. Pharmacoepidemiol Drug Saf 2012 1.86
9 FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf 2006 1.83
10 Validity of gout diagnoses in administrative data. Arthritis Rheum 2007 1.62
11 Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care 2006 1.60
12 Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation). Pharmacoepidemiol Drug Saf 2004 1.56
13 Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt) 2014 1.54
14 Challenges of estimating health service utilization for osteoarthritis patients on a population level. J Rheumatol 2002 1.48
15 Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs. J Manag Care Pharm 2006 1.46
16 Chronic disease score as a predictor of hospitalization. Epidemiology 2002 1.43
17 Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum 2008 1.38
18 Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf 2007 1.35
19 Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther 2009 1.35
20 Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics 2004 1.28
21 Risk factors for statin-associated rhabdomyolysis. Pharmacoepidemiol Drug Saf 2007 1.27
22 Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med 2008 1.25
23 Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med 2005 1.23
24 Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc 2005 1.22
25 Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data. Pharmacoepidemiol Drug Saf 2005 1.21
26 Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care 2006 1.14
27 Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf 2010 1.12
28 Consequences of poor compliance with bisphosphonates. Bone 2007 1.09
29 Medication adherence and use of generic drug therapies. Am J Manag Care 2009 1.08
30 Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr 2005 1.07
31 Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf 2007 1.04
32 Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health 2013 1.03
33 Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study. Paediatr Perinat Epidemiol 2012 0.96
34 Gastric and duodenal safety of daily alendronate. Arch Intern Med 2002 0.94
35 Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients. J Manag Care Pharm 2004 0.92
36 Older women's views about prescription osteoporosis medication: a cross-sectional, qualitative study. Drugs Aging 2010 0.91
37 Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf 2013 0.90
38 Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc 2005 0.90
39 Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response. J Natl Cancer Inst Monogr 2005 0.89
40 Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 2005 0.89
41 Adherence and occurrence of fractures after switching to once-monthly oral bisphophonates. Pharmacoepidemiol Drug Saf 2010 0.88
42 Statin discontinuation in nursing home residents with advanced dementia. J Am Geriatr Soc 2014 0.88
43 The dynamics of chronic gout treatment: medication gaps and return to therapy. Am J Med 2010 0.88
44 Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol 2013 0.87
45 Administrative data used to identify patients with irritable bowel syndrome. J Clin Epidemiol 2008 0.85
46 Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiol Drug Saf 2013 0.85
47 Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia? Ann Pharmacother 2007 0.85
48 Adoption of once-monthly oral bisphosphonates and the impact on adherence. Am J Med 2010 0.84
49 Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf 2009 0.84
50 Hormone therapy initiation after the Women's Health Initiative. Menopause 2008 0.83
51 The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative. J Gen Intern Med 2005 0.82
52 Beginning and duration of pregnancy in automated health care databases: review of estimation methods and validation results. Pharmacoepidemiol Drug Saf 2015 0.81
53 Bone density consequences of initiation and compliance with therapy for osteoporosis. Arthritis Care Res (Hoboken) 2010 0.80
54 Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf 2013 0.79
55 Communicating safety information to physicians: an examination of dear doctor letters. Pharmacoepidemiol Drug Saf 2005 0.78
56 The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007. Matern Child Health J 2014 0.78
57 Identification of patients with Churg-Strauss syndrome (CSS) using automated data. Pharmacoepidemiol Drug Saf 2004 0.78
58 Asthma drug use and the development of Churg-Strauss syndrome (CSS). Pharmacoepidemiol Drug Saf 2007 0.77
59 Risk management in therapeutics: when the patient becomes the last line of defense. Pharmacoepidemiol Drug Saf 2002 0.75
60 Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic. Pharmaceutics 2013 0.75
61 Response to the letter by Mol. Pharmacoepidemiol Drug Saf 2014 0.75